Skip to main content
. 2017 May 24;8:924. doi: 10.3389/fmicb.2017.00924

FIGURE 2.

FIGURE 2

Structures of the compounds evaluated in this work. MvfR antagonist 1, PqsBC inhibitors 2 and 3.